Steven Hersch Applebaum, MD

NPI 1295760221ActiveIndividual· Internal Medicine, Hematology & Oncology· Pasadena, CA

Internal Medicine, Hematology & Oncology (MD) in Pasadena, California, trained at University of Southern California Keck School of Medicine (class of 1990). Their prescriptions cost Medicare Part D more than their services did: $4,416,152 for 1,027 claims, against $1,584,564 paid for services in 2024. Incyte Corporation was the largest of 2 companies reporting payments in 2024, $1,356 in all, mostly travel and lodging.

Overview

NPI	1295760221
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jul 11, 2006
Last updated in NPPES	Jan 3, 2020
Certified by provider	Jan 3, 2020

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	G72790	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	775
Services billed	121,353 across 98 procedure codes
Paid by Medicare	$1,584,564

Part D prescriptions in 2024

Prescriptions (claims)	1,027 · 1,858 30-day fills
Patients	232
Total drug cost	$4,416,152
Generic share	67% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Southern California Keck School of Medicine
Graduation year	1990
Medicare specialty	Hematology/Oncology
Telehealth	Offers telehealth